2023 Symphony for a new dawn
The Candriam Outlook is back: 22 papers covering all our investment expertise will be produced and displayed all throughout the month of December, in an Advent calendar format.
Latest insights
-
ESG, Facial Recognition, Sophie Deleuze, SRIFacial recognition and human rights: Research Paper
It is estimated that one billion surveillance cameras are in operation[i]. The United Nations Guiding Principles on Business and Human Rights (UNGPs) urge companies to respect human rights and correct abuses when they occur. They call on companies to conduct human rights due diligence to “know and show” they respect human rights through their own activities, and the activities directly linked to their products, services, operations, and through their business relationships. -
Asset Allocation, Macro, Nadège Dufossé, Thibaud Marie-Regnault, VideoOverloaded by the sheer number of forecasts at the moment?
Despite this wealth of information – or perhaps because of too much information? – maybe you are still uncertain. We can help you organize and develop your views, in a 20-minute video. Our economists and strategists will try to clarify the economic and financial risks.
11 results found
-
Health Care
Equities, Health Care
HIV: the end of the tunnel?
Forty years after it first appeared, there is finally a realistic prospect of eradicating HIV using the combination of prevention and scientific advances
Equities, Health Care
Mental health: a priority investment area
Population ageing and the consequences of the pandemic will significantly increase the prevalence of mental illnesses in the years to come
Equities, Health Care
Diabetes: a silent and costly pandemic
14 November 2021 is an important day in the fight against diabetes as it marks the 30th World Diabetes Day
Equities, Health Care
New Blood: Innovative Companies Reduce Dependence on Donor Blood
By donating blood, you save lives. But the red fluid in our veins also has its limitations, and both the donation and transfusion of blood come with several challenges. Several of our portfolio companies have developed innovative solutions that can help patients with specific conditions become less dependent on donor blood.
Equities, Health Care, Monthly Coffee Break
Epidemic seemingly under control; economic risks postponed to 2022
European equities closed May up. After a relatively slow start, vaccination rates in Europe have picked up
Equities, Health Care
Giving blood: a vital need!
Recent scientific progress could soon mean that haematological diseases may be curable, starting with certain blood cancers. Meanwhile, every blood donation counts…
Equities, Health Care, Oncology
Cessation of tobacco use: a civic-minded investment!
Tobacco is considered as the leading risk factor of many chronic diseases
Equities, Health Care, Monthly Coffee Break
Mass vaccination fuels investor hopes
The global stock market concluded the year on an all-time high, with investors cheering the news flow and the start of the vaccination process in regions such as the US, the UK and the Eurozone, despite a pandemic still out of control in many of those – and other – regions.